Table 3

Unadjusted and adjusted effect of the intervention on self-reported non-adherence measured using the Diagnostic Adherence to Medication Scale at 4 week follow-up and 6 month follow-up

χ2Logistic RegressionGeneralised estimating equations analysis
Proportion <90% adherentUnadjustedAdjusted*Unadjusted
nInterventionControlp valuenOR (95% CI, p value)nOR (95% CI, p value)nOR (95% CI, p value)
Four-week follow-up
 Intention to treat (ITT)67739/340 (11.5)68/337 (20.2)6771.93 (1.22 to 3.05, 0.005)6772.20 (1.33 to 3.65, 0.002) 
 Available cases‡56419/270 (7.0)50/294 (17.0)0.0005642.71 (1.55 to 4.72, 0.000)5563.53 (1.87 to 6.67, 0.000) 
 Complete cases§49417/244 (7.0)39/250 (15.6)0.0044942.47 (1.35 to 4.50, 0.003)4943.43 (1.72 to 6.84, 0.000) 
6 month follow-up
 ITT67736/340 (10.6)66/337 (19.6)6772.04 (1.23 to 3.40, 0.006)6772.24 (1.29 to 3.88, 0.004)6771.54 (1.11 to 2.15, 0.010)
 Available cases54116/270 (5.9)41/271 (15.1)0.0015412.83 (1.55 to 5.18, 0.001)5323.40 (1.75 to 6.61, 0.000)6731.82 (1.26 to 2.61, 0.001)
 Complete cases49414/244 (5.7)35/250 (14.0)0.0034942.67 (1.40 to 5.11, 0.003)4943.48 (1.69 to 7.15, 0.001)4941.69 (1.10 to 2.61, 0.017)
  • *Logistic regression adjusted for age, gender, therapeutic group, number of prescription items, reminder service, baseline adherence

  • †No p values are provided for ITT analyses. SPSS does not support doing a χ2 test on imputed data sets.

  • ‡Available case analysis included all available data at each time point.

  • §Complete case analysis included only those who had questionnaire data available at all three data collection points.